Bellicum Pharmaceuticals Inc
BLCM
Get informed when a big investor buys or sells
+ FollowMarket Cap$778.33K
Close$
Share Statistics
| Market cap | $778,326.00 |
|---|---|
| Enterprise Value | $-5,130,674.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.81 |
| Beta | 1.38 |
| Outstanding Shares | 30,904,808 |
Return
| Return on Equity | 80.69% |
|---|---|
| Return on Assets | -318.07% |
| Return on Invested Capital | -494.50% |
Valuation & Multiples
| P/E Ratio | -0.09 |
|---|---|
| PEG | 0.1 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | -3.4 |
| Enterprise Value to EBIT | 0.23 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bellicum Pharmaceuticals Inc
CEO: Richard Fair